US3761585A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Vaccines containing modified allergenic material
Assignee: Beecham Group PLC
•
Filing: 1971-04-05
•
Granted: 1973-09-25
•
Expires: 1991-04-05
Abstract
Abstract Pharmaceutical preparations for parenteral administration are provided from modified allergenic material and a parenterally acceptable carrier. An adjuvant such as tyrosine may be included.
Inventors
- 👤 N Mullan
- 👤 B Overell
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-31 23:53
CPC Classifications
A; A61; A61K; A61K39/00; A61K39/35; A61K39/36; A61K2039/60; A61K2039/6012
Claims Analysis
Total Claims: 15
Claim 1
Independent Claim
11 words
A pharmaceutical preparation according to claim 1 further comprising an adjuvant.
Claim 2
Dependent Claim
20 words
A pharmaceutical preparation according to claim 2 wherein the adjuvant is selected from tyrosine, alumina, aluminum hydroxide and aluminum phosphate.
Claim 3
Dependent Claim
12 words
A pharmaceutical preparation according to claim 3 wherein the adjuvant is tyrosine.
Claim 4
Dependent Claim
17 words
A pharmaceutical composition according to claim 1 wherein said modified allergenic material is cross-linked to said dialdehyde.
Claim 5
Dependent Claim
22 words
A pharmaceutical composition according to claim 5 wherein the dialdehyde is an Alpha , omega -dialdehyde of 14 to 24 carbon atoms.
Claim 6
Dependent Claim
18 words
A pharmaceutical preparation according to claim 5 wherein the dialdehyde is 1,3-propanedial, 1,4-butanedial, glutaraldehyde or phenyl glyoxal hydrate.
Claim 7
Dependent Claim
16 words
A pharmaceutical preparation according to claim 1 wherein said modified allergenic material is cross-linked to glutaraldehyde.
Claim 8
Dependent Claim
17 words
A pharmaceutical composition according to claim 1 wherein said modified allergenic material is cross-linked to said carbodiimide.
Claim 9
Dependent Claim
14 words
A pharmaceutical preparation according to claim 9 wherein the carbodiimide is 1-cyclo-hexyl-3-(2-morpholinoethyl) carbodiimide metho-p-toluene-sulphonate.
Claim 10
Dependent Claim
17 words
A pharmaceutical composition according to claim 1 wherein said modified allergenic material is cross-linked to said epihalohydrin.
Claim 11
Dependent Claim
12 words
A pharmaceutical preparation according to claim 11 wherein the epihalohydrin is epichlorohydrin.
Claim 12
Dependent Claim
12 words
A pharmaceutical preparation according to claim 13 wherein the epihalohydrin is 1-bromo-2,3-epoxypropane.
Claim 13
Dependent Claim
18 words
A pharmaceutical composition according to claim 1 wherein said modified allergenic material is cross-linked to said inorganic cyanate.
Claim 14
Dependent Claim
22 words
A pharmaceutical preparation according to claim 14 wherein said inorganic cyanate is an alkali metal cyanate or an alkaline earth metal cyanate.
Claim 15
Dependent Claim
14 words
A pharmaceutical preparation according to claim 15 wherein said inorganIc cyanate is potassium cyanate.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1976-09-24 | 1977-03-26 | 1977-09-25 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1980-09-24 | 1981-03-26 | 1981-09-25 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1984-09-24 | 1985-03-26 | 1985-09-25 | $7700.00 | Window Closed / Lapsed |